Lockheed Martin Investment Management Co. Decreases Holdings in Danaher Co. (NYSE:DHR)

Lockheed Martin Investment Management Co. decreased its holdings in Danaher Co. (NYSE:DHR) by 53.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 18,550 shares of the conglomerate’s stock after selling 21,290 shares during the period. Lockheed Martin Investment Management Co.’s holdings in Danaher were worth $4,258,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in DHR. AMF Tjanstepension AB purchased a new stake in Danaher during the 3rd quarter valued at about $5,923,000. Czech National Bank boosted its stake in shares of Danaher by 4.2% during the third quarter. Czech National Bank now owns 130,939 shares of the conglomerate’s stock valued at $36,404,000 after purchasing an additional 5,320 shares during the period. GAMMA Investing LLC grew its holdings in shares of Danaher by 33.5% in the third quarter. GAMMA Investing LLC now owns 4,480 shares of the conglomerate’s stock worth $1,246,000 after purchasing an additional 1,125 shares during the last quarter. Diversified Trust Co increased its stake in shares of Danaher by 29.6% in the third quarter. Diversified Trust Co now owns 5,649 shares of the conglomerate’s stock worth $1,571,000 after buying an additional 1,289 shares during the period. Finally, Miracle Mile Advisors LLC bought a new stake in Danaher during the 3rd quarter valued at $310,000. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.4 %

NYSE:DHR opened at $215.05 on Wednesday. The stock has a market cap of $155.33 billion, a price-to-earnings ratio of 40.73, a PEG ratio of 2.80 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company’s 50 day moving average price is $234.93 and its 200-day moving average price is $252.88. Danaher Co. has a 52 week low of $210.04 and a 52 week high of $281.70.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the business posted $2.09 earnings per share. On average, equities research analysts forecast that Danaher Co. will post 7.77 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.50%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio is currently 20.45%.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on DHR. Citigroup decreased their price objective on shares of Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a research report on Thursday, January 30th. KeyCorp boosted their target price on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Wells Fargo & Company decreased their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday, January 30th. Finally, UBS Group cut their target price on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 10.90% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.